e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Cellular responses and cell therapy in lung injury and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations
E. Papakonstantinou (Basel/Thessaloniki, Switzerland), F. Baty (St. Gallen, Switzerland), M. Roth (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
Source:
International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Session:
Cellular responses and cell therapy in lung injury and repair
Session type:
Poster Discussion
Number:
3850
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Papakonstantinou (Basel/Thessaloniki, Switzerland), F. Baty (St. Gallen, Switzerland), M. Roth (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland). Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations. 3850
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Serum heparan sulfate levels predict the etiology of acute exacerbations in COPD
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations?
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Increased plasma fibrinogen could predict frequent exacerbations in asthma
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Low level of serum free triiodothyronine can be a predictor of long-term mortality after COPD exacerbations
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
Assessment of serum uric acid in COPD exacerbations
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Collagen degradation profile in serum of patients with COPD or IPF
Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways
Year: 2012
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002
Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Predictors of exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
Changes in the induced sputum proteome during COPD exacerbations
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept